Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 20,000 shares at $26.10 ($509K) on 2014-11-03, disclosed to the SEC on 2014-11-04.
Scheduled sale ($509k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.33 | 16,300 | $413K | 81.0% |
| 2 | $26.10 | 3,700 | $97K | 19.0% |
| Total | $25.47 avg | 20,000 | $509K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |